These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 11425770)

  • 1. Aspirin, warfarin, or the combination for secondary prevention of coronary events in patients with acute coronary syndromes and prior coronary artery bypass surgery.
    Huynh T; Théroux P; Bogaty P; Nasmith J; Solymoss S
    Circulation; 2001 Jun; 103(25):3069-74. PubMed ID: 11425770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Usefulness of antithrombotic therapy in resting angina pectoris or non-Q-wave myocardial infarction in preventing death and myocardial infarction (a pilot study from the Antithrombotic Therapy in Acute Coronary Syndromes Study Group).
    Cohen M; Adams PC; Hawkins L; Bach M; Fuster V
    Am J Cardiol; 1990 Dec; 66(19):1287-92. PubMed ID: 2244556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term oral anticoagulant therapy in patients with unstable angina or suspected non-Q-wave myocardial infarction: organization to assess strategies for ischemic syndromes (OASIS) pilot study results.
    Anand SS; Yusuf S; Pogue J; Weitz JI; Flather M
    Circulation; 1998 Sep; 98(11):1064-70. PubMed ID: 9736592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Warfarin plus aspirin after myocardial infarction or the acute coronary syndrome: meta-analysis with estimates of risk and benefit.
    Rothberg MB; Celestin C; Fiore LD; Lawler E; Cook JR
    Ann Intern Med; 2005 Aug; 143(4):241-50. PubMed ID: 16103468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Department of Veterans Affairs Cooperative Studies Program Clinical Trial comparing combined warfarin and aspirin with aspirin alone in survivors of acute myocardial infarction: primary results of the CHAMP study.
    Fiore LD; Ezekowitz MD; Brophy MT; Lu D; Sacco J; Peduzzi P;
    Circulation; 2002 Feb; 105(5):557-63. PubMed ID: 11827919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non-ST-elevation acute coronary syndrome: the Clopidogrel in Unstable angina to prevent Recurrent ischemic Events (CURE) Trial.
    Fox KA; Mehta SR; Peters R; Zhao F; Lakkis N; Gersh BJ; Yusuf S;
    Circulation; 2004 Sep; 110(10):1202-8. PubMed ID: 15313956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coronary artery flow ten weeks after myocardial infarction or unstable angina: effects of combined warfarin and aspirin therapy.
    Williams MJ; Stewart RA
    Int J Cardiol; 1999 Apr; 69(1):19-25. PubMed ID: 10362368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination antithrombotic therapy with antiplatelet agents and anticoagulants for patients with atherosclerotic heart disease.
    Arjomand H; Cohen M; Ezekowitz MD
    J Invasive Cardiol; 2004 May; 16(5):271-8. PubMed ID: 15152137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Organization to Assess Strategies for Ischemic Syndromes (OASIS) Pilot Study: evaluation of acute and long-term therapies for patients with acute coronary syndromes without ST elevation.
    Anand SS
    Am J Cardiol; 1999 Sep; 84(5A):13M-19M. PubMed ID: 10505538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antithrombotic treatment and the incidence of angina pectoris.
    Knottenbelt C; Brennan PJ; Meade TW;
    Arch Intern Med; 2002 Apr; 162(8):881-6. PubMed ID: 11966338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombosis prevention trial: randomised trial of low-intensity oral anticoagulation with warfarin and low-dose aspirin in the primary prevention of ischaemic heart disease in men at increased risk. The Medical Research Council's General Practice Research Framework.
    Lancet; 1998 Jan; 351(9098):233-41. PubMed ID: 9457092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risks and benefits of combining aspirin with anticoagulant therapy in patients with atrial fibrillation: an exploratory analysis of stroke prevention using an oral thrombin inhibitor in atrial fibrillation (SPORTIF) trials.
    Flaker GC; Gruber M; Connolly SJ; Goldman S; Chaparro S; Vahanian A; Halinen MO; Horrow J; Halperin JL;
    Am Heart J; 2006 Nov; 152(5):967-73. PubMed ID: 17070169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of antiplatelet therapy in acute coronary syndromes and for secondary prevention following a myocardial infarction.
    Jafri SM; Zarowitz B; Goldstein S; Lesch M
    Prog Cardiovasc Dis; 1993; 36(1):75-83. PubMed ID: 8321905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination antithrombotic therapy in unstable rest angina and non-Q-wave infarction in nonprior aspirin users. Primary end points analysis from the ATACS trial. Antithrombotic Therapy in Acute Coronary Syndromes Research Group.
    Cohen M; Adams PC; Parry G; Xiong J; Chamberlain D; Wieczorek I; Fox KA; Chesebro JH; Strain J; Keller C
    Circulation; 1994 Jan; 89(1):81-8. PubMed ID: 8281698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aspirin plus coumarin versus aspirin alone in the prevention of reocclusion after fibrinolysis for acute myocardial infarction: results of the Antithrombotics in the Prevention of Reocclusion In Coronary Thrombolysis (APRICOT)-2 Trial.
    Brouwer MA; van den Bergh PJ; Aengevaeren WR; Veen G; Luijten HE; Hertzberger DP; van Boven AJ; Vromans RP; Uijen GJ; Verheugt FW
    Circulation; 2002 Aug; 106(6):659-65. PubMed ID: 12163424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aspirin plus warfarin compared to aspirin alone after acute coronary syndromes: an updated and comprehensive meta-analysis of 25,307 patients.
    Andreotti F; Testa L; Biondi-Zoccai GG; Crea F
    Eur Heart J; 2006 Mar; 27(5):519-26. PubMed ID: 16143706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prior aspirin users with acute non-ST-elevation coronary syndromes are at increased risk of cardiac events and benefit from enoxaparin.
    Santopinto J; Gurfinkel EP; Torres V; Marcos E; Bozovich GE; Mautner B; McCabe CH; Antman EM
    Am Heart J; 2001 Apr; 141(4):566-72. PubMed ID: 11275921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The hemostatic effects of warfarin titration in post CABG patients in comparison to placebo treatment.
    Walenga JM; Hoppensteadt D; Pifarré R; Fox NL; Forman S; Hunninghake DB; Campeau L; Herd JA; Hoogwerf BJ; Hickey A; Probstfield JL; Terrin ML
    J Thromb Thrombolysis; 2001 Apr; 11(2):143-9. PubMed ID: 11406729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjusted indirect meta-analysis of aspirin plus warfarin at international normalized ratios 2 to 3 versus aspirin plus clopidogrel after acute coronary syndromes.
    Testa L; Zoccai GB; Porto I; Trotta G; Agostoni P; Andreotti F; Crea F
    Am J Cardiol; 2007 Jun; 99(12):1637-42. PubMed ID: 17560866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-molecular-weight heparin during instability in coronary artery disease, Fragmin during Instability in Coronary Artery Disease (FRISC) study group.
    Lancet; 1996 Mar; 347(9001):561-8. PubMed ID: 8596317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.